Nothing Special   »   [go: up one dir, main page]

Khare et al., 2015 - Google Patents

Mucoadhesive polymers for enhancing retention in ocular drug delivery

Khare et al., 2015

Document ID
8003055998392528548
Author
Khare A
Grover K
Pawar P
Singh I
Publication year
Publication venue
Progress in Adhesion and Adhesives. Hoboken, NJ: John Wiley & Sons, Inc

External Links

Snippet

Ocular drug delivery is a very challenging task faced by pharmaceutical scientists, inspite of the fact that eye is the most sensitive and accessible organ for the delivery of drugs. A major disadvantage associated with conventional dosage form is its low bioavailability, ie, less …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar, pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, copolymers of polyalkylene glycol or poloxamer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/4823—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative, e.g. starch, chitosan, chitin, cellulose, pectin, cyclodextrin with the pharmacologically active agent being covalently linked to the external surface of the ring structure, a bacterial polysaccharide or oligosaccharide antigen, a glycosaminoglycan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/72—Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides

Similar Documents

Publication Publication Date Title
Tundisi et al. Hydroxypropyl methylcellulose: Physicochemical properties and ocular drug delivery formulations
Khare et al. Mucoadhesive polymers for enhancing retention in ocular drug delivery: a critical review
Zhang et al. Hyaluronic acid in ocular drug delivery
Zamboulis et al. Chitosan and its derivatives for ocular delivery formulations: Recent advances and developments
Pahuja et al. Ocular drug delivery system: a reference to natural polymers
Nanjawade et al. RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery
Braga et al. Supercritical solvent impregnation of ophthalmic drugs on chitosan derivatives
JP7406634B2 (en) Soluble polymer ophthalmic inserts with biodegradable polymers
Wagh et al. Polymers used in ocular dosage form and drug delivery systems
Wadhwa et al. Chitosan and its role in ocular therapeutics
Vecchies et al. Complex coacervates between a lactose-modified chitosan and hyaluronic acid as radical-scavenging drug carriers
Naik et al. Mucoadhesive micro-/nano carriers in ophthalmic drug delivery: an overview
Khare et al. Mucoadhesive polymers for enhancing retention in ocular drug delivery
Luo et al. Effect of deacetylation degree on controlled pilocarpine release from injectable chitosan-g-poly (N-isopropylacrylamide) carriers
Karmakar et al. Recent progress in alginate-based carriers for ocular targeting of therapeutics
Manna et al. Marine polysaccharides in tailor-made drug delivery
Bisen et al. A review on polymers in ocular drug delivery systems
Zambito et al. Polysaccharides as excipients for ocular topical formulations
Biswas et al. Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision
Gharge et al. Recent trends in chitosan based nanotechnology: a reference to ocular drug delivery system
Lina Formica et al. Polysaccharide-based nanocarriers for ocular drug delivery
Sha et al. In situ gels: The next new frontier in ophthalmic drug delivery system
Sharma et al. Ocular Bioadhesive Drug Delivery Systems and Their Applications
Pawar et al. A review on topical ophthalmic drug delivery system: Reference to viscosity enhancer
Lopes et al. Application of chitosan based materials for drug delivery